Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study
-
Published:2015-08
Issue:12
Volume:51
Page:1497-1510
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Elshof Lotte E.,
Tryfonidis Konstantinos,
Slaets Leen,
van Leeuwen-Stok A. Elise,
Skinner Victoria P.,
Dif Nicolas,
Pijnappel Ruud M.,
Bijker Nina,
Rutgers Emiel J.Th.,
Wesseling JelleORCID
Funder
Pink Ribbon
Alpe d’Huzes/KWF
Subject
Cancer Research,Oncology
Cited by
277 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献